| Lupin Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500257 |
NSE Symbol : LUPIN |
P/E(TTM) : 18.83 |
|
ISIN Demat : INE326A01037 |
Div & Yield% : 0.53 |
EPS(TTM) : 120.95 |
|
Book Value(₹) : 595.49 |
Market Cap(₹Cr) : 104,140.83 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 4,433.96 | 3,852.79 | 5,605.41 | 4,382.69 | 4,060.16 | 3,931.73 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,433.96 | 3,852.79 | 5,605.41 | 4,382.69 | 4,060.16 | 3,931.73 |
| Other Operating Income | 67.23 | 215.49 | 103.18 | 102.98 | 147.84 | 174.47 |
| Other Income | 99.80 | 662.68 | 54.14 | 48.79 | 55.30 | 32.62 |
| Total Income | 4,600.99 | 4,730.96 | 5,762.73 | 4,534.46 | 4,263.30 | 4,138.82 |
| Total Expenditure | 3,518.35 | 2,892.65 | 2,978.95 | 2,739.54 | 2,874.17 | 2,991.45 |
| PBIDT | 1,082.64 | 1,838.31 | 2,783.78 | 1,794.92 | 1,389.13 | 1,147.37 |
| Interest | 36.02 | 27.78 | 18.90 | 33.85 | 19.55 | 17.55 |
| PBDT | 1,046.62 | 1,810.53 | 2,764.88 | 1,761.07 | 1,369.58 | 1,129.82 |
| Depreciation | 178.68 | 174.72 | 176.73 | 207.98 | 152.52 | 145.77 |
| Tax | 141.40 | 287.23 | 451.54 | 270.25 | 225.73 | 171.95 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 9.09 | -8.77 | 8.54 | -8.51 | 6.66 | 4.34 |
| Reported Profit After Tax | 717.45 | 1,357.35 | 2,128.07 | 1,291.35 | 984.67 | 807.76 |
| Extra-ordinary Items | -523.94 | 488.61 | 0.00 | 0.00 | -62.48 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1,241.39 | 868.74 | 2,128.07 | 1,291.35 | 1,047.15 | 807.76 |
| EPS (Unit Curr.) | 15.71 | 29.72 | 46.60 | 28.30 | 21.58 | 17.71 |
| EPS (Adj) (Unit Curr.) | 15.71 | 29.72 | 46.60 | 28.30 | 21.58 | 17.71 |
| Calculated EPS (Unit Curr.) | 15.70 | 29.71 | 46.59 | 28.28 | 21.58 | 17.71 |
| Calculated EPS (Adj) (Unit Curr.) | 15.70 | 29.71 | 46.59 | 28.28 | 21.58 | 17.71 |
| Calculated EPS (Ann.) (Unit Curr.) | 62.82 | 118.86 | 186.37 | 113.13 | 86.33 | 70.83 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 62.82 | 118.86 | 186.37 | 113.13 | 86.33 | 70.83 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 91.37 | 91.36 | 91.35 | 91.32 | 91.25 | 91.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21,887.03 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 24.42 | 47.71 | 49.66 | 40.95 | 34.21 | 29.18 |
| PBDTM(%) | 23.60 | 46.99 | 49.33 | 40.18 | 33.73 | 28.74 |
| PATM(%) | 16.18 | 35.23 | 37.96 | 29.46 | 24.25 | 20.54 |
